Which hedge funds own IMMX? IMMIX BIOPHARMA INC, Q2 2026 13F holders
4 of the hedge funds tracked by WhaleCreep disclosed a position in IMMX (IMMIX BIOPHARMA INC) in their Q2 2026 13F filings, worth $46.0m in total. The largest holder by portfolio weight is Marshall Wace at 0.0% of its book. 1 manager opened a new position this quarter: D. E. Shaw & Co. 1 exited: Brevan Howard Capital Management.
4tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold IMMX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Marshall Wace | Q2 2026 | 0.0% | $18.5m | 1,794,908 | 9% | added |
| Millennium Management | Q2 2026 | 0.0% | $21.3m | 2,066,426 | 18% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $5.2m | 506,157 | 973% | added |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $959.9k | 93,106 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $523.9k |
How has hedge fund ownership of IMMX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $46.0m |
| Q1 2026 | 4 | $31.9m |
| Q4 2025 | 1 | $1.4m |
| Q3 2025 | 1 | $44.9k |
| Q2 2024 | 1 | $306.3k |
| Q1 2024 | 1 | $815.0k |
| Q4 2023 | 1 | $224.0k |
| Q2 2023 | 1 | $29.0k |
| Q3 2022 | 1 | $37.0k |
| Q1 2022 | 1 | $151.0k |
Counts every tracked manager that disclosed IMMX in that quarter's filing, including managers that have since stopped filing.